Circadia Health

The page describes FDA-cleared contactless monitoring that predicts patient decline and reduces readmissions by about 30% in skilled nursing and post-acute care.

Circadia Health secures FDA 510(k) clearance for its **C200 System**, a contactless device monitoring **heart rate, respiratory rate, motion, and bed exits** in senior care settings. The system operates automatically and without supervision, expanding on the company’s prior **C100 System**, which focuses on continuous respiratory monitoring. The C200 marks the first FDA-cleared contactless solution for long-term, unattended senior health tracking.

Nov 2024BioSpaceNews article

Circadia Health partners with Ciena Healthcare’s 81 skilled nursing facilities to deploy remote monitoring technology. The collaboration targets preventive care improvements and aims to cut avoidable rehospitalizations by 25%. Early implementation focuses on real-time patient data tracking and clinician alerts.

Apr 2024McKnight's Long-Term Care NewsNews article

Circadia Health’s C100 system, tested in collaboration with Cleveland Clinic, predicts clinical deterioration in COVID-19 patients through continuous, contactless respiratory monitoring. The study shows the device can flag worsening conditions up to 24 hours before they occur, potentially improving early intervention and patient outcomes. Researchers highlight its role in enhancing remote and real-time patient care during respiratory crises.

Mar 2024PRWebNews article

Circadia Health secures FDA 510(k) clearance for its **C100 System**, a contactless radar-based monitor that measures respiration rates in adult patients from up to four feet away. The device targets deployment in hospitals, skilled nursing facilities, and other care settings amid high demand for respiratory illness management. The startup plans an immediate launch following regulatory approval.

Jun 2020TMG PulseNews article